| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.35e-03 | 1412 | 25 | 7 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.63e-03 | 1459 | 25 | 7 | GO:0000977 | |
| HumanPheno | Capillary fragility | 9.70e-06 | 7 | 4 | 2 | HP:0025017 | |
| HumanPheno | Decreased eosinophil count | 1.66e-05 | 9 | 4 | 2 | HP:0031891 | |
| HumanPheno | Intra-oral hyperpigmentation | 1.66e-05 | 9 | 4 | 2 | HP:0010284 | |
| HumanPheno | Abnormal capillary physiology | 2.08e-05 | 10 | 4 | 2 | HP:0025018 | |
| HumanPheno | Pituitary corticotropic cell adenoma | 3.04e-05 | 12 | 4 | 2 | HP:0008291 | |
| HumanPheno | Plethora | 4.20e-05 | 14 | 4 | 2 | HP:0001050 | |
| HumanPheno | Increased circulating ACTH level | 4.20e-05 | 14 | 4 | 2 | HP:0003154 | |
| HumanPheno | Optic nerve compression | 4.84e-05 | 15 | 4 | 2 | HP:0007807 | |
| HumanPheno | Large sella turcica | 4.84e-05 | 15 | 4 | 2 | HP:0002690 | |
| HumanPheno | Moon facies | 4.84e-05 | 15 | 4 | 2 | HP:0500011 | |
| HumanPheno | Paradoxical increased cortisol secretion on dexamethasone suppression test | 5.53e-05 | 16 | 4 | 2 | HP:0003466 | |
| HumanPheno | Increased urinary cortisol level | 5.53e-05 | 16 | 4 | 2 | HP:0012030 | |
| HumanPheno | Dorsocervical fat pad | 6.27e-05 | 17 | 4 | 2 | HP:0025383 | |
| HumanPheno | Psychotic episodes | 7.05e-05 | 18 | 4 | 2 | HP:0000725 | |
| HumanPheno | Livedo reticularis | 7.05e-05 | 18 | 4 | 2 | HP:0033505 | |
| HumanPheno | Abnormal urine hormone level | 7.87e-05 | 19 | 4 | 2 | HP:0012029 | |
| HumanPheno | Livedo | 8.75e-05 | 20 | 4 | 2 | HP:0033832 | |
| HumanPheno | Fatiguable weakness of proximal limb muscles | 1.06e-04 | 22 | 4 | 2 | HP:0030200 | |
| HumanPheno | Suicidal ideation | 1.16e-04 | 23 | 4 | 2 | HP:0031589 | |
| HumanPheno | Paranoia | 1.27e-04 | 24 | 4 | 2 | HP:0011999 | |
| HumanPheno | Adrenal hyperplasia | 1.38e-04 | 25 | 4 | 2 | HP:0008221 | |
| HumanPheno | Increased circulating cortisol level | 2.28e-04 | 32 | 4 | 2 | HP:0003118 | |
| HumanPheno | Cognitive distortion | 2.57e-04 | 34 | 4 | 2 | HP:5200242 | |
| HumanPheno | Abdominal obesity | 2.57e-04 | 34 | 4 | 2 | HP:0012743 | |
| HumanPheno | Impaired glucose tolerance | 3.05e-04 | 37 | 4 | 2 | HP:0040270 | |
| HumanPheno | Immunodeficiency | 3.16e-04 | 222 | 4 | 3 | HP:0002721 | |
| HumanPheno | Striae distensae | 3.22e-04 | 38 | 4 | 2 | HP:0001065 | |
| HumanPheno | Vertebral compression fracture | 3.75e-04 | 41 | 4 | 2 | HP:0002953 | |
| HumanPheno | Abnormal libido | 3.94e-04 | 42 | 4 | 2 | HP:0031845 | |
| HumanPheno | Abnormal sella turcica morphology | 3.94e-04 | 42 | 4 | 2 | HP:0002679 | |
| HumanPheno | Abnormal circulating adrenocorticotropin concentration | 4.33e-04 | 44 | 4 | 2 | HP:0011043 | |
| HumanPheno | Abnormal pigmentation of the oral mucosa | 4.33e-04 | 44 | 4 | 2 | HP:0100669 | |
| HumanPheno | Protruding tongue | 4.53e-04 | 45 | 4 | 2 | HP:0010808 | |
| HumanPheno | Fatigable weakness of skeletal muscles | 4.53e-04 | 45 | 4 | 2 | HP:0030197 | |
| HumanPheno | Flushing | 4.94e-04 | 47 | 4 | 2 | HP:0031284 | |
| HumanPheno | Oligomenorrhea | 5.15e-04 | 48 | 4 | 2 | HP:0000876 | |
| HumanPheno | Abnormal preoccupation | 5.60e-04 | 50 | 4 | 2 | HP:0025785 | |
| HumanPheno | Cranial nerve compression | 5.82e-04 | 51 | 4 | 2 | HP:0001293 | |
| HumanPheno | Poor wound healing | 6.05e-04 | 52 | 4 | 2 | HP:0001058 | |
| HumanPheno | Pituitary adenoma | 6.05e-04 | 52 | 4 | 2 | HP:0002893 | |
| HumanPheno | Delusion | 6.29e-04 | 53 | 4 | 2 | HP:0000746 | |
| HumanPheno | Ketonuria | 6.29e-04 | 53 | 4 | 2 | HP:0002919 | |
| HumanPheno | Pedal edema | 6.53e-04 | 54 | 4 | 2 | HP:0010741 | |
| HumanPheno | Lymphopenia | 6.72e-04 | 286 | 4 | 3 | HP:0001888 | |
| HumanPheno | Panic attack | 6.77e-04 | 55 | 4 | 2 | HP:0025269 | |
| HumanPheno | Adrenal overactivity | 6.77e-04 | 55 | 4 | 2 | HP:0002717 | |
| HumanPheno | Non-epileptic seizure | 7.02e-04 | 56 | 4 | 2 | HP:0033052 | |
| HumanPheno | Abnormality of cells of the lymphoid lineage | 7.51e-04 | 297 | 4 | 3 | HP:0012140 | |
| HumanPheno | Proximal amyotrophy | 7.53e-04 | 58 | 4 | 2 | HP:0007126 | |
| HumanPheno | Ecchymosis | 7.53e-04 | 58 | 4 | 2 | HP:0031364 | |
| HumanPheno | Abnormal bone marrow cell morphology | 8.11e-04 | 861 | 4 | 4 | HP:0005561 | |
| HumanPheno | Lack of skin elasticity | 8.33e-04 | 61 | 4 | 2 | HP:0100679 | |
| HumanPheno | Recurrent cutaneous fungal infections | 8.33e-04 | 61 | 4 | 2 | HP:0011370 | |
| HumanPheno | Abnormal granulocyte morphology | 9.11e-04 | 317 | 4 | 3 | HP:0001911 | |
| HumanPheno | Neoplasm of the anterior pituitary | 9.46e-04 | 65 | 4 | 2 | HP:0011750 | |
| HumanPheno | Neoplasm of the pituitary gland | 9.46e-04 | 65 | 4 | 2 | HP:0040277 | |
| HumanPheno | Abnormal lymphocyte count | 9.63e-04 | 323 | 4 | 3 | HP:0040088 | |
| HumanPheno | Abnormality of circulating cortisol level | 9.76e-04 | 66 | 4 | 2 | HP:0011731 | |
| HumanPheno | Abnormal eosinophil count | 9.76e-04 | 66 | 4 | 2 | HP:0020064 | |
| HumanPheno | Abnormality of circulating glucocorticoid level | 1.01e-03 | 67 | 4 | 2 | HP:0012111 | |
| HumanPheno | Secondary amenorrhea | 1.10e-03 | 70 | 4 | 2 | HP:0000869 | |
| HumanPheno | Acne | 1.13e-03 | 71 | 4 | 2 | HP:0001061 | |
| HumanPheno | Abnormal eosinophil morphology | 1.16e-03 | 72 | 4 | 2 | HP:0001879 | |
| HumanPheno | Abnormal myeloid leukocyte morphology | 1.18e-03 | 346 | 4 | 3 | HP:0010974 | |
| HumanPheno | Disorder of thought content | 1.29e-03 | 76 | 4 | 2 | HP:0025779 | |
| HumanPheno | Adrenocortical abnormality | 1.33e-03 | 77 | 4 | 2 | HP:0000849 | |
| HumanPheno | Truncal obesity | 1.50e-03 | 82 | 4 | 2 | HP:0001956 | |
| HumanPheno | Leukopenia | 1.51e-03 | 376 | 4 | 3 | HP:0001882 | |
| HumanPheno | Abnormality of subcutaneous fat tissue | 1.65e-03 | 86 | 4 | 2 | HP:0001001 | |
| HumanPheno | Macular purpura | 1.77e-03 | 89 | 4 | 2 | HP:0031365 | |
| HumanPheno | Thin skin | 1.81e-03 | 90 | 4 | 2 | HP:0000963 | |
| HumanPheno | Avascular necrosis | 1.89e-03 | 92 | 4 | 2 | HP:0010885 | |
| HumanPheno | Flat face | 2.50e-03 | 106 | 4 | 2 | HP:0012368 | |
| HumanPheno | Dermal atrophy | 2.55e-03 | 107 | 4 | 2 | HP:0004334 | |
| HumanPheno | Recurrent fungal infections | 2.70e-03 | 110 | 4 | 2 | HP:0002841 | |
| HumanPheno | Myocardial infarction | 2.74e-03 | 111 | 4 | 2 | HP:0001658 | |
| HumanPheno | Acute coronary syndrome | 2.74e-03 | 111 | 4 | 2 | HP:0033678 | |
| HumanPheno | Unusual fungal infection | 2.94e-03 | 115 | 4 | 2 | HP:0020100 | |
| HumanPheno | Fatigable weakness | 3.25e-03 | 121 | 4 | 2 | HP:0003473 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 3.31e-03 | 122 | 4 | 2 | HP:0003398 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 3.31e-03 | 122 | 4 | 2 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission | 3.31e-03 | 122 | 4 | 2 | HP:0012535 | |
| HumanPheno | Purpura | 3.86e-03 | 132 | 4 | 2 | HP:0000979 | |
| HumanPheno | Skin ulcer | 3.98e-03 | 134 | 4 | 2 | HP:0200042 | |
| HumanPheno | Abnormal lymphocyte morphology | 4.00e-03 | 524 | 4 | 3 | HP:0004332 | |
| HumanPheno | Abnormal leukocyte count | 4.18e-03 | 532 | 4 | 3 | HP:0011893 | |
| HumanPheno | Thin hair | 4.52e-03 | 143 | 4 | 2 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 4.52e-03 | 143 | 4 | 2 | HP:0002209 | |
| HumanPheno | Thin scalp hair | 4.52e-03 | 143 | 4 | 2 | HP:0002556 | |
| Domain | ZF_PHD_2 | 7.32e-06 | 95 | 25 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 7.63e-06 | 96 | 25 | 4 | PS01359 | |
| Domain | zf-C2H2 | 2.52e-05 | 693 | 25 | 7 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.54e-05 | 694 | 25 | 7 | IPR013087 | |
| Domain | Znf_FYVE_PHD | 4.10e-05 | 147 | 25 | 4 | IPR011011 | |
| Domain | ZINC_FINGER_C2H2_2 | 5.14e-05 | 775 | 25 | 7 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 5.23e-05 | 777 | 25 | 7 | PS00028 | |
| Domain | Znf_C2H2-like | 6.10e-05 | 796 | 25 | 7 | IPR015880 | |
| Domain | Znf_C2H2 | 6.55e-05 | 805 | 25 | 7 | IPR007087 | |
| Domain | ZnF_C2H2 | 6.70e-05 | 808 | 25 | 7 | SM00355 | |
| Domain | PHD | 1.34e-04 | 75 | 25 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 1.57e-04 | 79 | 25 | 3 | IPR019787 | |
| Domain | - | 2.21e-04 | 679 | 25 | 6 | 3.30.160.60 | |
| Domain | PHD | 2.23e-04 | 89 | 25 | 3 | SM00249 | |
| Domain | Znf_PHD | 2.38e-04 | 91 | 25 | 3 | IPR001965 | |
| Domain | UBIQUITIN_1 | 1.11e-03 | 37 | 25 | 2 | PS00299 | |
| Domain | UBIQUITIN_2 | 2.36e-03 | 54 | 25 | 2 | PS50053 | |
| Domain | SCAN | 2.53e-03 | 56 | 25 | 2 | SM00431 | |
| Domain | SCAN_BOX | 2.72e-03 | 58 | 25 | 2 | PS50804 | |
| Domain | SCAN | 2.72e-03 | 58 | 25 | 2 | PF02023 | |
| Domain | Ubiquitin_dom | 2.72e-03 | 58 | 25 | 2 | IPR000626 | |
| Domain | SCAN_dom | 2.72e-03 | 58 | 25 | 2 | IPR003309 | |
| Domain | - | 2.79e-03 | 449 | 25 | 4 | 3.30.40.10 | |
| Domain | Retrov_capsid_C | 2.81e-03 | 59 | 25 | 2 | IPR008916 | |
| Domain | Znf_RING/FYVE/PHD | 3.02e-03 | 459 | 25 | 4 | IPR013083 | |
| Domain | Zinc_finger_PHD-type_CS | 3.40e-03 | 65 | 25 | 2 | IPR019786 | |
| Domain | RING | 7.60e-03 | 305 | 25 | 3 | SM00184 | |
| Domain | zf-C2H2_6 | 8.23e-03 | 314 | 25 | 3 | PF13912 | |
| Domain | Znf_RING | 9.12e-03 | 326 | 25 | 3 | IPR001841 | |
| Pubmed | 9.70e-06 | 181 | 26 | 4 | 37372979 | ||
| Pubmed | 3.49e-05 | 251 | 26 | 4 | 28077445 | ||
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 6.61e-05 | 105 | 26 | 3 | 19156129 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 7.79e-05 | 608 | 26 | 5 | 36089195 | |
| Pubmed | 1.60e-04 | 25 | 26 | 2 | 36343752 | ||
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 1.73e-04 | 26 | 26 | 2 | 34162889 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.90e-04 | 150 | 26 | 3 | 28242625 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.99e-04 | 394 | 26 | 4 | 27248496 | |
| Pubmed | 2.63e-04 | 32 | 26 | 2 | 38060382 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.03e-04 | 440 | 26 | 4 | 34244565 | |
| Pubmed | 3.09e-04 | 177 | 26 | 3 | 26206133 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.18e-04 | 1294 | 26 | 6 | 30804502 | |
| Pubmed | 3.86e-04 | 469 | 26 | 4 | 27634302 | ||
| Pubmed | 5.02e-04 | 503 | 26 | 4 | 16964243 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 6.24e-04 | 533 | 26 | 4 | 30554943 | |
| Interaction | NSD1 interactions | 1.33e-05 | 119 | 25 | 4 | int:NSD1 | |
| Cytoband | 19p13.2 | 2.93e-04 | 229 | 26 | 3 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.94e-04 | 797 | 26 | 4 | chr19p13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.28e-06 | 718 | 18 | 7 | 28 | |
| GeneFamily | PHD finger proteins | 9.22e-05 | 90 | 18 | 3 | 88 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 5.14e-06 | 199 | 26 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 9.28e-05 | 152 | 26 | 3 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.46e-04 | 177 | 26 | 3 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 177 | 26 | 3 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 177 | 26 | 3 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.66e-04 | 185 | 26 | 3 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 1.74e-04 | 188 | 26 | 3 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 189 | 26 | 3 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.79e-04 | 190 | 26 | 3 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.82e-04 | 191 | 26 | 3 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-04 | 191 | 26 | 3 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 192 | 26 | 3 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 192 | 26 | 3 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 192 | 26 | 3 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 195 | 26 | 3 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-04 | 196 | 26 | 3 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-04 | 196 | 26 | 3 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 197 | 26 | 3 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 197 | 26 | 3 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 197 | 26 | 3 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 2.03e-04 | 198 | 26 | 3 | 84a07dea22b7771b34118729607b48c2d75df870 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 2.06e-04 | 199 | 26 | 3 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 2.06e-04 | 199 | 26 | 3 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 2.06e-04 | 199 | 26 | 3 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.06e-04 | 199 | 26 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 2.06e-04 | 199 | 26 | 3 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 5.08e-05 | 189 | 25 | 4 | 4271_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 5.29e-05 | 191 | 25 | 4 | 5214_DN | |
| Drug | 5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.73e-05 | 195 | 25 | 4 | 920_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 4814_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 2256_DN | |
| Disease | Tourette syndrome, schizophrenia | 9.62e-05 | 18 | 24 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Adenoid Cystic Carcinoma | 2.99e-03 | 100 | 24 | 2 | C0010606 | |
| Disease | blood phosphate measurement | 8.76e-03 | 174 | 24 | 2 | EFO_0010972 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPIKIRGPSHCAGCK | 141 | O94929 | |
| CPDKSFGSKCKSPLG | 496 | Q9C0A0 | |
| RLCTNPKPSHGGKFC | 611 | Q8TE57 | |
| GPNKCKCHPGYAGKT | 71 | Q6UXI9 | |
| KTKKSPGSGCILAHC | 1581 | P46100 | |
| EQCKPHKRPVCGSNG | 56 | Q12841 | |
| GSPHSCKCGRNKKTP | 536 | O75751 | |
| PCGSPKKCNLKGAFV | 1026 | Q5THK1 | |
| AVCKKVGACHGPRTP | 461 | Q6NUJ1 | |
| GHKEPRNPNCQGSCK | 936 | P0DKV0 | |
| ASPPSNKLCCSKGSK | 341 | Q9NUC0 | |
| RKHTGEKPFECPKCG | 311 | P10074 | |
| VHRKGKTKVCPHPGC | 491 | Q96CK0 | |
| KAKRPKPHCFNCGSE | 221 | Q6NZY4 | |
| GPHKCKICGKGFLSP | 306 | Q8N8Z8 | |
| GPHKCKICGKSFDSP | 501 | Q8N8Z8 | |
| SPTKSKVTSCPGCRK | 766 | Q9NXC5 | |
| PSKQCGFCKKPHGNR | 716 | Q92576 | |
| KTGQHPCFSCKVSGK | 746 | Q9BZ95 | |
| NPTGEKPHKCSECGR | 586 | Q6ZN19 | |
| PHKCKICGKGFDRPS | 336 | Q8TA94 | |
| DNPMRRKSGPSCKHC | 291 | Q96T88 | |
| HTGGKPHKCNKCGKA | 531 | Q6ZN08 | |
| KPHTVPCKVTGRCGS | 176 | P15880 | |
| SQTRKPKCGKGTHCS | 396 | Q86UV5 | |
| KPHKCSKCPRAFGRP | 466 | A6NGD5 | |
| KSPGEKPHRCPQCGK | 316 | Q6P9G9 |